News | May 19, 2010

St. Jude Acquires LightLab, OCT Imaging

May 20, 2010 – St. Jude Medical Inc. announced yesterday it is purchasing LightLab Imaging Inc. for $90 million. Lightlab makes optical coherence tomography (OCT) intravascular imaging systems. Earlier this month its OCT system became the first cleared by the U.S. Food and Drug Administration (FDA).

The high-resolution diagnostic coronary imaging technology aids physicians in the treatment of cardiovascular disease. OCT has been shown to provide image resolution 10 times greater than intravascular ultrasound (IVUS) imaging systems and 20 times faster image capture.

During the second half of 2010, St. Jude Medical expects the OCT platform to contribute an additional $20 million in revenue to its cardiovascular business. The OCT market is expected to grow at a double-digit compounded annual rate over the next five years and is expected to capture IVUS market share as well as expand the market for coronary imaging. The IVUS market is estimated to be $500 million for 2010, and is growing 10 to 15 percent annually. OCT coronary imaging is expected to grow at an even faster rate within this market.

OCT combined with FFR
Upon closing, St. Jude Medical will be the first company to offer a portfolio that includes both OCT and fractional flow reserve (FFR) technology. No other OCT systems are currently available for coronary imaging. This leading combination will provide physicians with comprehensive lesion assessment information, ranging from the anatomical images of OCT to the physiological data of FFR. St. Jude Medical acquired its FFR measurement technology platform through the acquisition of Radi Medical Systems AB in 2008. The LightLab business will become part of the St. Jude Medical Cardiovascular Division.

Lightlab’s OCT System

The FDA cleared LightLab’s C7-XR OCT imaging system and companion C7 Dragonfly imaging catheter is comprised of a console used in the cath lab and the catheter inserted into the vessel. This allows the clinician to readily see and measure important vessel characteristics otherwise invisible or difficult to observe with IVUS or angiography.
This next generation OCT system eliminates the need for temporary vessel occlusion that was required by the earlier generation OCT systems.

LightLab now has products approved in 40 countries, including the only OCT system cleared for use by regulatory bodies in the U.S., Europe and Japan.

Purchase details
The transaction is expected to close by the end of the second quarter 2010 and is subject to customary closing conditions and regulatory approvals. Except for a nonrecurring charge to be recorded at the time of closing, this acquisition does not change St. Jude Medical’s outlook for 2010 consolidated earnings per share.

In connection with the transaction, Bank of America Merrill Lynch is acting as financial advisor and Gibson, Dunn & Crutcher LLP as legal advisor to St. Jude Medical. Brown Brothers Harriman is acting as financial advisor to LightLab and Choate, Hall & Stewart LLP as legal counsel. Kitahama Partners, LLC is acting as legal counsel to Goodman Co. Ltd., the current owner of Lightlab.

For more information: www.lightlabimaging.com

Related Content

ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography
Technology | Artificial Intelligence | November 09, 2018
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest...
Siemens Healthineers Announces FDA Clearance of Cios Spin Mobile 3D C-Arm
Technology | Mobile C-Arms | November 06, 2018
Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 25, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campa
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cardiac Imaging | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...

Image courtesy of Siemens Healthineers

Feature | CT Angiography (CTA) | September 06, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology....
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...